Affinivax   Report issue

For profit Phase 2
Founded: Cambridge MA United States (2014)
Status: Acquired by GlaxoSmithKline (2022)

Organization Overview

First Clinical Trial
2019
NCT03803202
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Affinivax | Affinivax, Inc.